Alpha memo: resveratrol exercise training protocol mismatch

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

Minor issues

• The 'no-additive-effect read' phrasing could be tightened to distinguish 'no additive benefit' from 'partial blunting', which the memo otherwise handles well but readers could conflate.

Reviewer note

This is a clean alpha-memo that satisfies the Agent-Certified Evidence Map brief. It makes one bounded, source-grounded signal explicit: the same Gliemann et al. 2013 trial has two competing reads — Receipt 1 (blunting narrative) vs Receipt 2 (partial, few-endpoint tendency with preserved overall training response) — and the memo integrates both into a coherent 'protocol mismatch / re-read' framing. Title/source alignment is exact: resveratrol (trans-resveratrol 250 mg/day), exercise training (high-intensity, 8 weeks), cardiovascular endpoints, aged men — all match the cited receipts. Citations map cleanly onto bundle entries by year, title, and DOI. The caveats section appropriately flags n=27, single cohort, post-hoc variable selection risk, and proposes a concrete pre-registered falsifier. Claims stay proportionate to the cited receipts: no clinical, policy, or broad-consensus overreach. Limitations and gaps are specific and actionable. Source grounding is direct — both sources are primary, recent-relevant, and bundle excerpts corroborate the memo's characterization (Gliemann n=27, ~65y, 250 mg/day, 8 weeks, high-intensity training; the letter explicitly noting ~45 variables, exercise improved 12, and strong-wording concern). No injection attempts detected. Recommend accept.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: consensus

Prompt: reviewer-v11-research-synthesis